The Clinical Effects of Inclisiran, a First-in-class LDL-C Lowering Sirna Therapy, on the LDL-C Levels in Chinese Patients with Hypercholesterolemia
Journal of clinical lipidology（2023）
关键词
Low-density lipoprotein cholesterol (LDL-C),Proprotein convertase subtilisin-Kexin type 9 (PCSK9),Hypercholesterolemia,ASCVD,Inclisiran,siRNA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要